샘플 요청 목록

 카트 문의
시장보고서
상품코드
1760821

세계의 단일 광자 방출 컴퓨터 단층촬영(SPECT) 시장

Single Photon Emission Computed Tomography (SPECT)
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 469 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

단일 광자 방출 컴퓨터 단층촬영(SPECT) 세계 시장은 2030년까지 33억 달러에 이를 전망

2024년에 22억 달러로 추정되는 단일 광자 방출 컴퓨터 단층촬영(SPECT) 세계 시장은 2024-2030년간 CAGR 7.1%로 성장하여 2030년에는 33억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 심장병학은 CAGR 8.1%를 나타내고, 분석 기간 종료시에는 13억 달러에 이를 것으로 예측됩니다. 종양학 분야의 성장률은 분석 기간 CAGR로 7.1%로 추정됩니다.

미국 시장은 7억 9,000만 달러로 추정, 중국은 CAGR 9.7%로 성장 예측

미국의 단일 광자 방출 컴퓨터 단층촬영(SPECT) 시장은 2024년에 7억 9,000만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 3억 9,860만 달러 규모에 이를 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 9.7%로 예상됩니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 5.8%와 6.6%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 5.7%를 보일 전망입니다.

세계의 단일 광자 방출 컴퓨터 단층촬영(SPECT) 시장 - 주요 동향과 촉진요인 정리

단일 광자 방출 컴퓨터 단층촬영(SPECT)은 핵의학 분야에서 널리 사용되는 첨단 영상 기술입니다. 이 기술은 방사성 추적자에서 방출되는 감마선을 감지하여 체내의 대사 및 생리적 과정을 3차원적으로 시각화할 수 있습니다. 이러한 추적자는 일반적으로 혈류에 주입되며, 사용된 추적자의 유형에 따라 특정 조직, 장기 또는 세포 수용체에 축적됩니다. SPECT는 심장학, 종양학, 신경학에서 특히 유용하며, 관상동맥 질환, 종양, 간질 및 알츠하이머병과 같은 신경 질환과 같은 질환에 대한 중요한 통찰력을 제공합니다. SPECT의 기능적 영상진단 능력은 주로 해부학적 정보를 제공하는 CT나 MRI와 같은 다른 영상진단법과 차별화됩니다.

기술의 발전은 SPECT의 능력과 응용을 크게 향상시켰으며, SPECT와 컴퓨터 단층촬영(SPECT/CT)의 통합은 기능적 영상과 해부학적 영상을 한 번의 세션에서 결합하여 이 분야에 혁명을 일으켰습니다. 이 하이브리드 접근법은 진단 정확도를 향상시키고, 이상 부위의 국소화와 특징을 보다 명확하게 파악할 수 있습니다. 카드뮴-아연 카드뮴 텔룰라이드(CZT) 검출기 사용과 같은 최근 검출기 기술 개발 동향은 SPECT 시스템의 감도와 해상도를 향상시켜 촬영 시간을 단축하고 환자의 피폭선량을 감소시킬 수 있게 되었습니다. 또한, 영상 재구성 및 영상 처리를 위한 소프트웨어 알고리즘의 발전으로 SPECT 영상의 품질과 정량적 정확도가 향상되었습니다. 이러한 기술 혁신으로 SPECT는 임상과 연구 양면에서 유용성이 확대되어 현대 의료에 필수적인 도구가 되었습니다.

SPECT 시장의 성장은 몇 가지 요인에 의해 주도되고 있습니다. 심혈관 질환, 암, 신경 질환과 같은 만성 질환의 유병률 증가는 진단 및 관리를 위해 상세한 기능적 영상이 필요한 경우가 많기 때문에 주요 촉진요인이 되고 있습니다. 하이브리드 SPECT/CT 시스템의 개발, 검출기 재료 및 영상처리 알고리즘의 개선을 포함한 기술적 발전은 SPECT의 임상적 유용성과 보급을 크게 향상시키고 있습니다. 또한, 개인 맞춤형 의료가 강조되면서 환자 개개인에 맞는 치료를 위한 정확한 진단 도구의 필요성이 SPECT와 같은 고급 영상 진단 양식에 대한 수요를 부추기고 있습니다. 만성질환에 취약한 노령인구 증가는 SPECT의 잠재적 시장을 더욱 확대시키고 있습니다. 마지막으로, 방사성의약품의 가용성 증가와 전 세계 핵의학 시설의 확대도 시장 성장에 기여하고 있습니다. 이러한 요인들이 SPECT 시장의 역동적이고 발전적인 특성을 뒷받침하고 있습니다.

부문

제품 유형(스탠드얼론, 하이브리드), 용도(심장병학, 종양학, 신경학, 기타 용도), 최종 용도(병원, 진단센터, 기타 최종 용도)

조사 대상 기업 예(총 45개사)

  • GE Healthcare
  • Cardinal Health, Inc.
  • Bruker Corporation
  • Agfa-Gevaert NV
  • Analogic Corporation
  • Biosensors International Group Ltd.
  • Koninklijke Philips N.V.
  • Bracco SpA
  • Digirad Corporation
  • Bracco Imaging SpA
  • CMR Naviscan Corporation
  • BC Technical, Inc.
  • DDD-Diagnostic A/S
  • Cubresa Inc.
  • Beijing Hamamatsu Photon Techniques, Inc.

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해서, 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • SPECT-CT
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.07.07

Global Single Photon Emission Computed Tomography (SPECT) Market to Reach US$3.3 Billion by 2030

The global market for Single Photon Emission Computed Tomography (SPECT) estimated at US$2.2 Billion in the year 2024, is expected to reach US$3.3 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Cardiology, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Oncology segment is estimated at 7.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$790.0 Million While China is Forecast to Grow at 9.7% CAGR

The Single Photon Emission Computed Tomography (SPECT) market in the U.S. is estimated at US$790.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$398.6 Million by the year 2030 trailing a CAGR of 9.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.8% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR.

Global Single Photon Emission Computed Tomography (SPECT) Market - Key Trends & Drivers Summarized

Single Photon Emission Computed Tomography (SPECT) is a sophisticated imaging technique widely used in the field of nuclear medicine. This modality allows for three-dimensional visualization of metabolic and physiological processes in the body by detecting gamma rays emitted from radioactive tracers. These tracers are typically injected into the bloodstream and accumulate in specific tissues, organs, or cellular receptors, depending on the type of tracer used. SPECT is particularly valuable in cardiology, oncology, and neurology, providing critical insights into conditions such as coronary artery disease, tumors, and neurological disorders like epilepsy and Alzheimer's disease. The ability of SPECT to provide functional imaging distinguishes it from other imaging modalities like CT and MRI, which primarily offer anatomical information.

Technological advancements have significantly enhanced the capabilities and applications of SPECT. The integration of SPECT with computed tomography (SPECT/CT) has revolutionized the field by combining functional and anatomical imaging in a single session. This hybrid approach improves diagnostic accuracy and allows for better localization and characterization of abnormalities. Recent developments in detector technology, such as the use of cadmium zinc telluride (CZT) detectors, have increased the sensitivity and resolution of SPECT systems, enabling faster acquisition times and reduced radiation doses for patients. Furthermore, advancements in software algorithms for image reconstruction and processing have improved the quality and quantitative accuracy of SPECT images. These innovations have expanded the utility of SPECT in both clinical practice and research, making it an indispensable tool in modern healthcare.

The growth in the SPECT market is driven by several factors. Increasing prevalence of chronic diseases such as cardiovascular diseases, cancer, and neurological disorders is a major driver, as these conditions often require detailed functional imaging for diagnosis and management. Technological advancements, including the development of hybrid SPECT/CT systems and improvements in detector materials and image processing algorithms, have significantly enhanced the clinical utility and adoption of SPECT. Additionally, the growing emphasis on personalized medicine and the need for precise diagnostic tools to tailor treatments to individual patients are fueling demand for advanced imaging modalities like SPECT. The rising geriatric population, which is more susceptible to chronic diseases, further expands the potential market for SPECT. Lastly, the increasing availability of radiopharmaceuticals and the expansion of nuclear medicine facilities worldwide are also contributing to market growth. These factors collectively underscore the dynamic and evolving nature of the SPECT market.

SCOPE OF STUDY:

The report analyzes the Single Photon Emission Computed Tomography (SPECT) market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Standalone, Hybrid); Application (Cardiology, Oncology, Neurology, Other Applications); End-Use (Hospitals, Diagnostic Centers, Other End-Uses)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 45 Featured) -

  • GE Healthcare
  • Cardinal Health, Inc.
  • Bruker Corporation
  • Agfa-Gevaert NV
  • Analogic Corporation
  • Biosensors International Group Ltd.
  • Koninklijke Philips N.V.
  • Bracco SpA
  • Digirad Corporation
  • Bracco Imaging SpA
  • CMR Naviscan Corporation
  • BC Technical, Inc.
  • DDD-Diagnostic A/S
  • Cubresa Inc.
  • Beijing Hamamatsu Photon Techniques, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Single Photon Emission Computed Tomography (SPECT) - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • A Prelude to Single-Photon Emission Computed Tomography (SPECT)
    • Prominent Indications for SPECT Scanning
    • Global SPECT Market to Witness Steady Growth over the Coming Years
    • Hybrid SPECT Systems Witness Increased Demand.
    • Cardiology Dominates the Application for SPECT
    • Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
    • United States Dominates the Global SPECT Market, Asia-Pacific to Register Faster Growth
    • Competition
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • SPECT Dominates the Nuclear Medicine Market
    • Global Radiopharmaceuticals Market Revenues in U$ Million for Years 2019, 2021, 2023 & 2025
    • SPECT Systems with Anger Camera Remain the Dominant Type
    • Rapidly Growing Geriatric Population and the Rise in Associated Diseases Catalyze Growth
    • Global Population of 65+ Individuals (In 000s) by Region for the Years 2015, 2020, 2025, 2030 & 2050
    • Rising Incidence of Chronic Diseases Propels the Demand for Medical Imaging
    • Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030
    • Oncology Diagnostic Imaging to Witness Rapid Growth
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • Growing Emphasis on Early Diagnosis is a Driving Factor for Diagnostic Imaging
    • Rise in Healthcare Expenditure to Drive Growth
    • Elderly Healthcare Expenditure as a % of GDP
    • SPECT Systems with Anger Camera Remain the Dominant Type
    • Growing Demand for Dual-Modality and Organ-Specific Systems Augurs Well
    • Growing Adoption of Hybrid Diagnostic Imaging Modalities
  • SPECT-CT
    • Commercialization of SPECT/CT Systems with Enhanced Features Surges
    • SPECT Combined with CT and PET, the new Rage
    • Integration of X-ray CT Enhances SPECT Capabilities
    • Proper Selection of Isotopes Highly Important for SPECT
    • Sustained Opportunities for Ga-67 SPECT Systems
    • PET Eclipses SPECT in Cardiovascular Imaging
    • Personalized Medicine Drives SPECT Market
    • Drug Ineffectiveness for Select Therapeutic Categories as a Percentage of Patient Population
    • Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019 and 2024
    • Rise in Incidence of Neurological Disorders to Drive Growth
    • Technological Advancements in the Recent Past
    • Yale University Research Team Attempts to use Deep Learning for Estimating Attenuation Maps using SPECT Emission Data
    • Siemens Healthineers Debuts New Version of c.cam Cardiac SPECT System
    • NorthStar Medical Radioisotopes Advances Focus on Therapeutic and Specialized SPECT Radiopharmaceuticals
    • Technological Advancements in Cardiac SPECT
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Standalone by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Standalone by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Standalone by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hybrid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Hybrid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Hybrid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 28: World Single Photon Emission Computed Tomography (SPECT) Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • AUSTRALIA
    • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 164: India Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • IRAN
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제